Sessions include:

• Nitrosamines & IGG
• New Investigators Session
• New technologies
• Cancer / Disease Prevention
• Environmental Aspects

Including talks from David Lovell and Awadhesh Jha (2019 and 2021 Jim Parry Award Winners) and Helena Reinardy (2022 UKEMS Young Scientist).

The full program can be found on the conference website here.

IGG hosted session on Monday 4th July 9:00-12:30 will be chaired by: Paul Fowler (FSTox Consulting Ltd) & Robert Smith (Labcorp Drug Development)

The talks in this session will include:

• An introduction to N-Nitrosamines, Jo Elloway – AstraZeneca
• Structure-activity relationships for nitrosamine mutagenicity and carcinogenicity, David Ponting – Lhasa Limited
• Can the Ames test adequately predict the carcinogenic potential of N-nitrosamines? Rachael Tennant – Lhasa Limited
• Quantitative Analysis of In Vivo Mutagenicity Dose Response Data for Risk Assessment and Regulatory Decision-making: A Case Study of Nitrosamines, George Johnson – Swansea University
• Establishing laboratory proficiency in the OECD 488 big blue® transgenic rodent somatic and germ cell mutation assay, Karen Philp – Gentronix
• Comparison of lowest positive concentrations for inducers of MN in vivo with in vitro positive concentrations (IVIVC), James Whitwell – Labcorp Drug Development
• A weight of evidence review of the genotoxicity of Titanium Dioxide, David Kirkland – Kirkland Consulting (presented by Carol Beevers)

The winner of the 2020 Richard Williams Memorial Award, Amy Wilson, presented her work on Tuesday 5th July 2022.

The title of her presentation was: High content, high throughput, image based genotoxicity screen: micronucleus assessment and beyond.

Congratulation Amy Wilson and to all the prize winners at UKEMS 2022.